These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8629259)

  • 1. [Significance, diagnosis and prognosis in the cytogenetic analysis in acute leukemias and myelodysplastic syndromes].
    Jotterand Bellomo M
    Ther Umsch; 1996 Feb; 53(2):103-10. PubMed ID: 8629259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical importance of karyotype in hematology].
    Bellomo MJ
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):26-36. PubMed ID: 8296188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
    Castro Volio I; Montero Umaña C; Jiménez Cruz G
    Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of chromosome number deviations in myelodysplastic syndromes and in acute non-lymphoid leukemia].
    Balogh E; Oláh E; Nagy A; Kovács I; Kiss A
    Orv Hetil; 1989 Mar; 130(13):655-63. PubMed ID: 2657551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation.
    Breccia M; Mancini M; Nanni M; D'Elia GM; Carmosino I; Latagliata R; Sarlo C; Mandelli F; Alimena G
    Leuk Res; 2005 Jan; 29(1):33-9. PubMed ID: 15541472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
    Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
    Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Karyotype studies of patients with a myelodysplastic syndrome].
    Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
    Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of cytogenetic analysis in the diagnosis of leukemia].
    Kamada N; Takauchi K; Tashiro S
    Rinsho Byori; 1991 Dec; 39(12):1250-6. PubMed ID: 1779462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
    Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
    Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities.
    Estey EH; Pierce S; Keating MJ
    Haematologica; 2000 Mar; 85(3):246-9. PubMed ID: 10702811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
    Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosome abnormalities in leukemia in children. Occurrence and clinical significance].
    Hählen K; Hagemeijer A
    Tijdschr Kindergeneeskd; 1982 Dec; 50(6):198-203. PubMed ID: 6963036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of chromosomal abnormalities in acute leukaemias and myelodysplastic syndromes.
    Yunis JJ; Brunning RD
    Clin Haematol; 1986 Aug; 15(3):597-620. PubMed ID: 3536236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.